isoxazoles has been researched along with Crohn Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, RW; Li, HY; Li, JS; Miao, XP; Ouyang, Q; Zhang, Y | 1 |
| Sachar, DB | 1 |
| Binion, DG; Csuka, ME; Emmons, J; Knox, JF; Prajapati, DN; Saeian, K | 1 |
| Barde, C; Borradori, L; Janer, V; Saurat, JH; Thielen, AM | 1 |
| Galle, PR; Gerts, AL; Holtmann, MH; Neurath, MF; Weinman, A | 1 |
| Favilli, F; Ferretti, P; Iantomasi, T; Marraccini, P; Tonelli, F; Vincenzini, MT | 1 |
1 review(s) available for isoxazoles and Crohn Disease
| Article | Year |
|---|---|
Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Colitis, Ulcerative; Crohn Disease; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Humans; Isoxazoles; Lactones; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Safety-Based Drug Withdrawals; Sulfonamides; Sulfones | 2014 |
1 trial(s) available for isoxazoles and Crohn Disease
| Article | Year |
|---|---|
Treatment of Crohn's disease with leflunomide as second-line immunosuppression : a phase 1 open-label trial on efficacy, tolerability and safety.
Topics: Adult; Anti-Inflammatory Agents; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2008 |
4 other study(ies) available for isoxazoles and Crohn Disease
| Article | Year |
|---|---|
Leflunomide in Crohn's disease--the open-label case series and the Texas sharpshooter.
Topics: Crohn Disease; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Treatment Outcome | 2003 |
Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy.
Topics: Adjuvants, Immunologic; Adult; Aged; Crohn Disease; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Retrospective Studies; Treatment Failure | 2003 |
Reiter syndrome triggered by adalimumab (Humira) and leflunomide (Arava) in a patient with ankylosing spondylarthropathy and Crohn disease.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Reactive; Crohn Disease; Humans; Isoxazoles; Leflunomide; Male; Spondylarthropathies | 2007 |
Glutathione metabolism in Crohn's disease.
Topics: Administration, Oral; Animals; Antimetabolites; Antioxidants; Buthionine Sulfoximine; Crohn Disease; Female; gamma-Glutamyltransferase; Glutamate-Cysteine Ligase; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Glutathione Transferase; Humans; Ileum; Isoxazoles; Jejunum; Male; Methionine Sulfoximine; Rats; Rats, Sprague-Dawley | 1994 |